Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (42 ops.)
Latest filing published 17 Jun 2026 for Ironwood Pharmaceuticals INC.
Filing timeline
BuySaleMark G. Currie
Insider track record
Disclosed buys
1
Disclosed sells
42
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark G. Currie: trading record in brief
Mark G. Currie is a declared insider at 2 companies (board member); the most frequent names are Ironwood Pharmaceuticals Inc and Korsana Biosciences, Inc. Over a trading history stretching from 22 February 2011 to 16 June 2026, the count stands at 107 filings.
In open-market terms, that means 1 purchase worth €3.6M on one side and 42 sales worth €21.3M on the other. Sales outweigh purchases by €17.7M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 13 share grants and 45 option exercises.
The latest filing, published on 17 June 2026, reports a share grant in Ironwood Pharmaceuticals Inc. The last purchase on record was published on 3 April 2019, which is 2,763 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark G. Currie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations107 total
63,481 sharesClass A Common StockSEC:0001193125-26-274288:0
45,000 shares0Class A Common StockSEC:0000950170-25-085440:0
24,311 shares0Class A Common StockSEC:0000950170-24-076206:0
22,350 shares0Class A Common StockSEC:0001209191-23-039132:0
70,000 shares@ US$11.7825.8% of flowClass A Common StockSEC:0001209191-22-045808:0
190,383 shares@ US$12.018.2% of flowClass A Common StockSEC:0001209191-22-035443:1
190,383 shares@ US$11.6566.9% of flowClass A Common StockSEC:0001209191-22-035443:0
21,571 shares0Class A Common StockSEC:0001209191-22-033983:0
23,571 shares@ US$11.597.3% of flowClass A Common StockSEC:0001209191-21-040892:0
22,766 shares0Class A Common StockSEC:0001209191-21-038179:0
20,107 shares@ US$3.0130.5% of flowCommon StockSEC:0001140361-20-029869:0
21,720 shares0Class A Common StockSEC:0001209191-20-034692:0
60,000 shares@ US$9.123.6% of flowClass A Common StockSEC:0001209191-20-004855:0
60,000 shares@ US$12.595.0% of flowClass A Common StockSEC:0001209191-20-004855:1
8,888 shares@ US$10.020.6% of flowClass A Common StockSEC:0001209191-20-004301:0
8,888 shares@ US$12.800.8% of flowClass A Common StockSEC:0001209191-20-004301:1
25,000 shares@ US$2.5535.3% of flowCommon StockSEC:0001209191-19-062322:0
25,000 shares@ US$2.4834.1% of flowCommon StockSEC:0001209191-19-062322:1
1,837 shares0Class A Common StockSEC:0001209191-19-061136:0
500 shares0Class A Common StockSEC:0001209191-19-061136:1
22,706 shares0Class A Common StockSEC:0001209191-19-033615:0
4,055 shares@ US$10.530.2% of flowClass A Common StockSEC:0001209191-19-029601:0
51,648 shares0Common StockSEC:0001209191-19-023521:0
270,107 shares@ US$14.81Common StockSEC:0001209191-19-023521:1
Canonical exit: 1 Jul 2019 (T+90)
1,483 sharesClass A Common StockSEC:0001209191-19-023438:0
25 of 107 declarations
